Manager with over 25 years of practice in the pharmaceutical industry. He has international experience in the ongoing management of pharmaceutical companies and the implementation of long-term development strategies.
For many years he specialized in building product portfolios, as well as creating and maintaining strategic partnerships with leading global players. His experience with the global pharmaceutical market is a valuable source of knowledge for the industry, as evidenced by the frequent participation of Mieczysław Starkowicz in international advisory panels such as Medicines for Europe.
A graduate of the Medical University of Gdańsk and INSEAD with an MBA.
Since 2022, he has been the President of the Management Board of Synthaverse. Previously associated with such companies as: Farmaprojects, Polpharma Group, Akrikhin, ICN - currently Bausch Health, Stiefel Polska.
Enthusiast of teamwork with high business awareness and excellent legal education.
Experienced in leading interdisciplinary projects and with impressive strategic and operational skills. Self-confident and excellent in managing crisis situations. IR, restructuring, fundraising (capital, debt, EU subsidies), change management.
A graduate of law studies at the Maria Curie-Skłodowska University in Lublin, as well as the Executive MBA program at the Warsaw School of Economics. He completed a lawyer's apprenticeship.
A leader at the management board level and an active lawyer with over ten years of experience. Member of the Management Board of Synthaverse and legal advisor since 2021. Until 2021, he ran his own law firm and was the head of the legal department at Synthaverse.